• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients.不同钙网蛋白基因突变类型在野生型JAK2原发性血小板增多症和骨髓纤维化患者中的临床意义
Haematologica. 2014 Oct;99(10):e182-4. doi: 10.3324/haematol.2014.109199. Epub 2014 Jul 11.
2
Mutation status of essential thrombocythemia and primary myelofibrosis defines clinical outcome.原发性血小板增多症和原发性骨髓纤维化的突变状态决定临床结局。
Haematologica. 2016 Apr;101(4):e129-32. doi: 10.3324/haematol.2015.138958. Epub 2016 Jan 14.
3
Somatic mutations of calreticulin in myeloproliferative neoplasms.髓系增殖性肿瘤中的钙网织蛋白体细胞突变。
N Engl J Med. 2013 Dec 19;369(25):2379-90. doi: 10.1056/NEJMoa1311347. Epub 2013 Dec 10.
4
Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.伴有钙网蛋白突变的骨髓增殖性肿瘤的独特临床特征。
Haematologica. 2014 Jul;99(7):1184-90. doi: 10.3324/haematol.2014.107482. Epub 2014 Jun 3.
5
Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations.伴有CALR或JAK2突变的原发性血小板增多症的表型与预后分析。
Haematologica. 2015 Jul;100(7):893-7. doi: 10.3324/haematol.2014.118299. Epub 2015 May 1.
6
JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis.韩国原发性血小板增多症和原发性骨髓纤维化患者的JAK2 V617F、MPL及CALR突变
J Korean Med Sci. 2015 Jul;30(7):882-8. doi: 10.3346/jkms.2015.30.7.882. Epub 2015 Jun 10.
7
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis.CALR 外显子 9 突变是家族性原发性血小板增多症或原发性骨髓纤维化病例中的体细胞获得性事件。
Blood. 2014 Apr 10;123(15):2416-9. doi: 10.1182/blood-2014-01-550434. Epub 2014 Feb 19.
8
Calreticulin mutation burden--is it a stable clone in patients with essential thrombocythemia and myelofibrosis?钙网蛋白突变负荷——它在原发性血小板增多症和骨髓纤维化患者中是一个稳定的克隆吗？
Blood Cells Mol Dis. 2015 Dec;55(4):281-3. doi: 10.1016/j.bcmd.2015.07.011. Epub 2015 Jul 18.
9
Capricious CALR mutated clones in myeloproliferative neoplasms.骨髓增殖性肿瘤中反复无常的CALR突变克隆
Blood Cells Mol Dis. 2016 Mar;57:110-1. doi: 10.1016/j.bcmd.2016.01.001. Epub 2016 Jan 7.
10
Incidence, clinical features, and prognostic impact of CALR exon 9 mutations in essential thrombocythemia and primary myelofibrosis: an experience of a single tertiary hospital in Korea.韩国一家三级医院的经验：真性红细胞增多症和原发性骨髓纤维化中CALR外显子9突变的发生率、临床特征及预后影响
Ann Lab Med. 2015 Mar;35(2):233-7. doi: 10.3343/alm.2015.35.2.233. Epub 2015 Feb 12.

引用本文的文献

1
Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology.血栓性骨髓增殖性肿瘤的分子遗传学：对精准肿瘤学的启示
Diagnostics (Basel). 2023 Jan 3;13(1):163. doi: 10.3390/diagnostics13010163.
2
Mutation profile in Indian primary myelofibrosis patients and its clinical implications.印度原发性骨髓纤维化患者的突变谱及其临床意义。
South Asian J Cancer. 2019 Jul-Sep;8(3):186-188. doi: 10.4103/sajc.sajc_276_18.
3
[Clinical significance of JAK2、CALR and MPL gene mutations in 1 648 Philadelphia chromosome negative myeloproliferative neoplasms patients from a single center].[单中心1648例费城染色体阴性骨髓增殖性肿瘤患者中JAK2、CALR和MPL基因突变的临床意义]
Zhonghua Xue Ye Xue Za Zhi. 2017 Apr 14;38(4):295-300. doi: 10.3760/cma.j.issn.0253-2727.2017.04.007.
4
Screening PCR Versus Sanger Sequencing: Detection of CALR Mutations in Patients With Thrombocytosis.筛查聚合酶链反应与桑格测序：血小板增多症患者中CALR突变的检测
Ann Lab Med. 2016 Jul;36(4):291-9. doi: 10.3343/alm.2016.36.4.291.
5
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis.1型/1型样与2型/2型样CALR突变在骨髓纤维化中的差异预后影响的验证
Blood Cancer J. 2015 Oct 16;5(10):e360. doi: 10.1038/bcj.2015.90.
6
The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia.骨髓增殖性肿瘤和急性白血病患者中钙网蛋白的突变谱
Turk J Haematol. 2016 Sep 5;33(3):180-6. doi: 10.4274/tjh.2015.0220. Epub 2015 Aug 6.
7
Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms.中国CALR突变型骨髓增殖性肿瘤患者的频率、实验室特征及粒细胞活化
PLoS One. 2015 Sep 16;10(9):e0138250. doi: 10.1371/journal.pone.0138250. eCollection 2015.
8
[CALR gene mutation detection and clinical observation of 150 essential thrombocythemia patients].150例原发性血小板增多症患者CALR基因突变检测及临床观察
Zhonghua Xue Ye Xue Za Zhi. 2015 May;36(5):378-82. doi: 10.3760/cma.j.issn.0253-2727.2015.05.005.
9
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.217 例原发性骨髓纤维化或特发性血小板增多症青年患者的突变和长期结局。
Leukemia. 2015 Jun;29(6):1344-9. doi: 10.1038/leu.2015.87. Epub 2015 Mar 24.
10
A meta-analysis comparing clinical characteristics and outcomes in CALR-mutated and JAK2V617F essential thrombocythaemia.一项比较CALR突变型和JAK2V617F突变型原发性血小板增多症临床特征及预后的荟萃分析。
Int J Hematol. 2015 Feb;101(2):165-72. doi: 10.1007/s12185-014-1724-6. Epub 2014 Dec 25.

本文引用的文献

1
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis.CALR 外显子 9 突变是家族性原发性血小板增多症或原发性骨髓纤维化病例中的体细胞获得性事件。
Blood. 2014 Apr 10;123(15):2416-9. doi: 10.1182/blood-2014-01-550434. Epub 2014 Feb 19.
2
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.骨髓增殖性肿瘤体细胞突变的克隆进化及其临床相关性。
Blood. 2014 Apr 3;123(14):2220-8. doi: 10.1182/blood-2013-11-537167. Epub 2014 Jan 29.
3
Genetics of myeloproliferative neoplasms.骨髓增殖性肿瘤的遗传学
Cancer J. 2014 Jan-Feb;20(1):61-5. doi: 10.1097/PPO.0000000000000013.
4
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia.钙网织蛋白突变对原发性血小板增多症的临床和血液学表型及预后的影响。
Blood. 2014 Mar 6;123(10):1552-5. doi: 10.1182/blood-2013-11-538983. Epub 2013 Dec 26.
5
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.JAK2 或 CALR 突变状态定义了具有显著不同临床过程和结局的特发性血小板增多症亚型。
Blood. 2014 Mar 6;123(10):1544-51. doi: 10.1182/blood-2013-11-539098. Epub 2013 Dec 23.
6
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.伴有未突变 JAK2 的骨髓增殖性肿瘤中的体细胞 CALR 突变。
N Engl J Med. 2013 Dec 19;369(25):2391-2405. doi: 10.1056/NEJMoa1312542. Epub 2013 Dec 10.
7
Somatic mutations of calreticulin in myeloproliferative neoplasms.髓系增殖性肿瘤中的钙网织蛋白体细胞突变。
N Engl J Med. 2013 Dec 19;369(25):2379-90. doi: 10.1056/NEJMoa1311347. Epub 2013 Dec 10.
8
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).国际预后评分血栓形成在世界卫生组织原发性血小板增多症（IPSET-thrombosis）中的开发和验证。
Blood. 2012 Dec 20;120(26):5128-33; quiz 5252. doi: 10.1182/blood-2012-07-444067. Epub 2012 Oct 1.
9
The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues.Ph 阳性和 Ph 阴性骨髓增殖性肿瘤：一些热门的临床前和临床问题。
Haematologica. 2011 Apr;96(4):590-601. doi: 10.3324/haematol.2010.035675. Epub 2011 Jan 17.
10
Myeloproliferative disorders.骨髓增殖性疾病
Blood. 2008 Sep 15;112(6):2190-8. doi: 10.1182/blood-2008-03-077966.

Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients.

作者信息

Qiao Chun, Sun Chao, Ouyang Yuan, Wang Ju-Juan, Qian Si-Xuan, Li Jian-Yong, Zhang Su-Jiang

机构信息

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

出版信息

Haematologica. 2014 Oct;99(10):e182-4. doi: 10.3324/haematol.2014.109199. Epub 2014 Jul 11.

DOI:10.3324/haematol.2014.109199
PMID:25015940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4181265/
Abstract
摘要